Literature DB >> 11122786

Dietary supplements and cardiovascular disease.

R M DeBusk1.   

Abstract

Consumer use of dietary supplements has increased considerably in recent years, and interest in using supplements to treat or prevent chronic diseases such as cardiovascular disease is particularly high. This review examines several popular dietary supplements used for cardiovascular disease, their likely points of intervention, and what is known to date about their efficacy and safety.

Entities:  

Mesh：

Year:  2000        PMID： 11122786     DOI： 10.1007/s11883-000-0051-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  44 in total

1.  The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease.

Authors:  O Johansen; I Seljeflot; A T Høstmark; H Arnesen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

2.  Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion.

Authors:  J Rowin; S L Lewis
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

3.  Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation.

Authors:  H M Roche; M J Gibney
Journal:  Eur J Clin Nutr       Date:  1996-09       Impact factor: 4.016

4.  Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension.

Authors:  D L Sherman; J F Keaney; E S Biegelsen; S J Duffy; J D Coffman; J A Vita
Journal:  Hypertension       Date:  2000-04       Impact factor: 10.190

5.  Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease.

Authors:  H Tagawa; H Shimokawa; T Tagawa; M Kuroiwa-Matsumoto; Y Hirooka; A Takeshita
Journal:  J Cardiovasc Pharmacol       Date:  1999-04       Impact factor: 3.105

6.  Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

Authors:  T A Mori; V Burke; I B Puddey; G F Watts; D N O'Neal; J D Best; L J Beilin
Journal:  Am J Clin Nutr       Date:  2000-05       Impact factor: 7.045

7.  Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart.

Authors:  S al Makdessi; H Sweidan; K Dietz; R Jacob
Journal:  Basic Res Cardiol       Date:  1999-04       Impact factor: 17.165

8.  Medical edema protection--clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study.

Authors:  C Diehm; D Vollbrecht; K Amendt; H U Comberg
Journal:  Vasa       Date:  1992       Impact factor: 1.961

9.  Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial.

Authors:  J L Isaacsohn; M Moser; E A Stein; K Dudley; J A Davey; E Liskov; H R Black
Journal:  Arch Intern Med       Date:  1998-06-08

10.  Garlic as a lipid lowering agent--a meta-analysis.

Authors:  C Silagy; A Neil
Journal:  J R Coll Physicians Lond       Date:  1994 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.